hydroxychloroquine has been researched along with dinoprostone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Chetrit, E; Fischel, R; Hinz, B; Levy, M | 1 |
| Caughey, GE; Cleland, LG; James, MJ; Proudman, SM | 1 |
| Hämäläinen, M; Moilanen, E; Moilanen, T; Tuure, L | 1 |
1 trial(s) available for hydroxychloroquine and dinoprostone
| Article | Year |
|---|---|
Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arachidonic Acid; Arthritis, Rheumatoid; Cardiovascular Diseases; Dietary Supplements; Dinoprostone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eicosanoids; Female; Fish Oils; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Risk Factors; Sulfasalazine; Thromboxane A2 | 2006 |
2 other study(ies) available for hydroxychloroquine and dinoprostone
| Article | Year |
|---|---|
The effects of colchicine and hydroxychloroquine on the cyclo-oxygenases COX-1 and COX-2.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gout Suppressants; Humans; Hydroxychloroquine; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Thromboxane A2 | 2005 |
Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes.
Topics: Antirheumatic Agents; Chondrocytes; Dexamethasone; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Enzymologic; Glucocorticoids; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Intramolecular Oxidoreductases; Methotrexate; Osteoarthritis, Knee; Primary Cell Culture; Prostaglandin-E Synthases; Real-Time Polymerase Chain Reaction; Sulfasalazine | 2015 |